Artemis DNA Founder and CEO, Emylee Thai, Nominated for OCBJ Women in Business Awards

Artemis DNA Founder and CEO, Emylee Thai, Nominated for OCBJ Women in Business Awards

Irvine, Calif., August 9, 2021 — Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high complexity clinical diagnostic laboratory company providing proprietary Next Generation Sequencing (NGS) genetic and diagnostic testing that enables precision medicine through early disease detection, today announced that Founder and CEO, Emylee Thai, has been nominated for Orange County Business Journal’s Women in Business 2021.  The annual list of nominees will be released this fall and highlights over 180 of Orange County’s most exceptional women in business.  This is the 27th annual publication of the OCBJ Women in Business.

“I could not be more thrilled to be nominated amongst such influential and powerful women in the region,” commented Ms. Thai, Founder and CEO of Artemis DNA.  “My team and I have worked tirelessly to build Artemis DNA into what we are today, and I humbled and honored to be recognized as a leader.”

Ms. Thai has over a decade of experience in the healthcare industry having worked in various capacities for several top-tier firms including serving as the CEO for Orion Modern, an innovative healthcare focused strategy and consulting firm, as well as the CEO of FindDoctr, a technology company that connects patient with medical care professionals.  A serial entrepreneur with a proven history of success, Ms. Thai was motivated to start Artemis DNA by a passion to make innovative, affordable and actionable healthcare solutions accessible to all.


Artemis DNA is a full service, Clinical Laboratory Improvement Amendments (CLIA) certified, College of American Pathologists (CAP) accredited, high-complexity clinical diagnostic laboratory company that provides proprietary Next Generation Sequencing (NGS) genetic testing and diagnostic laboratory services for a wide variety of medical specialties, including cardiology, oncology, immunology, neurology, reproductive health and pharmacogenomics.

Artemis DNA’s testing enhances the delivery of “personalized medicine” by assessing a patient’s own genetic makeup and clinical characteristics which allows for informed decision making in prevention and treatment choices.  Artemis DNA also provides pre- and post-testing genetic education and counseling services, as well as conducting research and development to discover and develop additional novel diagnostic services.  Artemis DNA is headquartered in Irvine, California. For more information, visit https://www.artemisdna.com.



Emylee Thai (Founder and CEO)
Email: pr@artemisdna.com
Phone: (888) 88DNA88, Extension 8


Artemis DNA